20:58:48 EDT Tue 23 Apr 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:APS from 2018-04-24 to 2019-04-23 - 37 items News ReleasesIn The NewsOther
DateSymCompanyPriceTypeHeadline
2019-04-23 08:16APSAptose Biosciences Inc (2)2.55News ReleaseAptose Biosciences to provide Q1 results on May 7
2019-04-01 13:08APSAptose Biosciences Inc (2)2.74News ReleaseAptose talks CG-806, APTO-253 preclinical data
2019-03-25 08:15APSAptose Biosciences Inc (2)3.10News ReleaseAptose granted IND allowance for CG-806 trial
2019-03-12 20:12APSAptose Biosciences Inc (2)2.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-03-12 20:12APSAptose Biosciences Inc (2)2.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-03-12 20:12APSAptose Biosciences Inc (2)2.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-03-12 20:05APSAptose Biosciences Inc (2)2.30SEDAR MD & ASEDAR MD & A
2019-03-12 20:05APSAptose Biosciences Inc (2)2.30SEDAR Annual ReportSEDAR Annual Report
2019-03-12 20:05APSAptose Biosciences Inc (2)2.30SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2019-03-12 16:15APSAptose Biosciences Inc (2)2.30News ReleaseAptose Biosciences spends $18.73-million in 2018
2019-03-04 08:22APSAptose Biosciences Inc (2)2.36News ReleaseAptose receives Australian patent for CG-806
2019-02-26 08:57APSAptose Biosciences Inc (2)2.53News ReleaseAptose Biosciences to release 2018 results March 12
2019-02-25 09:03APSAptose Biosciences Inc (2)2.59News ReleaseAptose Biosciences submits IND application for CG-806
2018-12-03 08:29APSAptose Biosciences Inc (2)3.03News ReleaseAptose presents CG-806 data at hematology meeting
2018-11-26 08:36APSAptose Biosciences Inc (2)2.88News ReleaseAptose begins dosing first patient for APTO-253 study
2018-11-06 18:07APSAptose Biosciences Inc (2)3.16SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2018-11-06 18:07APSAptose Biosciences Inc (2)3.16SEDAR MD & ASEDAR MD & A
2018-11-06 16:31APSAptose Biosciences Inc (2)3.16News ReleaseAptose Biosciences has R&D expenses of $3.59M in Q3
2018-10-23 08:32APSAptose Biosciences Inc (2)2.79News ReleaseAptose Biosciences to release Q3 2018 results Nov. 6
2018-09-27 09:15APSAptose Biosciences Inc (2)3.51News ReleaseAptose Biosciences receives European patent for CG-806
2018-08-15 08:05APSAptose Biosciences Inc (2)4.09News ReleaseAptose Biosciences appoints Ashe to board
2018-08-07 17:44APSAptose Biosciences Inc (2)3.58SEDAR MD & ASEDAR MD & A
2018-08-07 17:37APSAptose Biosciences Inc (2)3.58SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2018-08-07 16:34APSAptose Biosciences Inc (2)3.58News ReleaseAptose has R&D expenses of $7.81M (U.S.) in Q2
2018-07-24 08:15APSAptose Biosciences Inc (2)3.94News ReleaseAptose Biosciences to release Q2 2018 results Aug. 7
2018-07-10 08:25APSAptose Biosciences Inc (2)4.61News ReleaseAptose Biosciences receives Japanese patent for CG-806
2018-06-29 08:24APSAptose Biosciences Inc (2)5.01News ReleaseAptose Biosciences to return APTO-253 to phase 1b trial
2018-06-14 09:23APSAptose Biosciences Inc (2)5.08News ReleaseAptose signs licence deal with CrystalGenomics
2018-06-05 16:18APSAptose Biosciences Inc (2)4.66News ReleaseAptose shareholders elect six directors
2018-06-04 08:22APSAptose Biosciences Inc (2)4.66News ReleaseAptose Biosciences publishes APTO-253 preclinical data
2018-05-31 09:32APSAptose Biosciences Inc (2)4.61News ReleaseAptose, Aspire sign $20M (U.S.) share purchase deal
2018-05-10 17:27APSAptose Biosciences Inc (2)4.14SEDAR MD & ASEDAR MD & A
2018-05-10 17:26APSAptose Biosciences Inc (2)4.14SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2018-05-10 16:18APSAptose Biosciences Inc (2)4.14News ReleaseAptose loses $6.81-million (U.S.) in Q1
2018-05-07 08:26APSAptose Biosciences Inc (2)4.20News ReleaseAptose Biosciences exercises option for CG-806 licence
2018-05-01 09:58APSAptose Biosciences Inc (2)4.18News ReleaseAptose to release Q1 results May 10
2018-04-25 07:50APSAptose Biosciences Inc (2)4.10News ReleaseAptose Biosciences appoints Loewy to board